Literature DB >> 31376308

Pain inhibitory mechanisms and response to weak analgesics in patients with knee osteoarthritis.

Kristian Kjaer Petersen1,2, Ole Simonsen3,4, Anne Estrup Olesen3,5, Carsten Dahl Mørch1,2, Lars Arendt-Nielsen1.   

Abstract

BACKGROUND: Conditioned pain modulation (CPM) and offset analgesia are different features of descending pain inhibition. This study investigated CPM, offset analgesia and clinical pain measures in patients with knee osteoarthritis (KOA) before and after treatment with the combination of a non-steroidal anti-inflammatory drug (NSAIDs) plus acetaminophen.
METHODS: Forty-two patients with KOA received Ibuprofen 1.2 g/daily and acetaminophen 3.0 g/daily for three weeks. Before administration, CPM magnitude was assessed as the difference between cuff pain detection (cPDT) with and without a conditioning stimulus (evoked by tourniquet pain). Offset analgesia was assessed as the pain intensities evoked by a constant 46°C for 30-s stimulus compared to an offset analgesia paradigm of 46°C for 5-s, 47°C for 5-s and 46°C for 20-s. The worst pain within the last 24-hr and pain during activity were assessed before and after treatment.
RESULTS: Clinical pain significantly decreased after treatment (p < 0.001) and less efficient CPM before treatment was associated with weaker analgesic effect (R = 0.354, p = 0.043). No significant modulation of CPM or offset analgesia was found for the treatment.
CONCLUSION: This study found that less efficient CPM is associated with reduced analgesic effect of NSAIDs plus acetaminophen in patients with KOA whereas the treatment did not modulate CPM nor offset analgesia magnitude. SIGNIFICANCE: This study demonstrated that conditioned pain modulation is correlated with the response to a standard pharmaceutical interventions treating osteoarthritis pain. Furthermore, we demonstrated that a decrease in clinical pain intensity is not associated with a normalization of conditioned pain modulation or offset analgesia, which questions if restoring these descending pain inhibitory mechanisms are pain intensity driven.
© 2019 European Pain Federation - EFIC®.

Entities:  

Year:  2019        PMID: 31376308     DOI: 10.1002/ejp.1465

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  12 in total

1.  The association between sleep quality, preoperative risk factors for chronic postoperative pain and postoperative pain intensity 12 months after knee and hip arthroplasty.

Authors:  Dennis Boye Larsen; Mogens Laursen; Ole Simonsen; Lars Arendt-Nielsen; Kristian Kjær Petersen
Journal:  Br J Pain       Date:  2021-11-15

2.  Commentary: Novel Use of Offset Analgesia to Assess Adolescents and Adults with Treatment Resistant Endometriosis-Associated Pain.

Authors:  Claire E Lunde; Edina Szabo; Scott A Holmes; David Borsook; Christine B Sieberg
Journal:  J Pain Res       Date:  2020-11-02       Impact factor: 3.133

3.  Association of Dysregulated Central Pain Processing and Response to Disease-Modifying Antirheumatic Drug Therapy in Rheumatoid Arthritis.

Authors:  Andrew C Heisler; Jing Song; Lutfiyya N Muhammad; Alyssa Wohlfahrt; Wendy Marder; Marcy B Bolster; Clifton O Bingham; Daniel J Clauw; Dorothy D Dunlop; Tuhina Neogi; Yvonne C Lee
Journal:  Arthritis Rheumatol       Date:  2020-11-04       Impact factor: 10.995

Review 4.  What goes up must come down: insights from studies on descending controls acting on spinal pain processing.

Authors:  Stevie Lockwood; Anthony H Dickenson
Journal:  J Neural Transm (Vienna)       Date:  2019-09-12       Impact factor: 3.575

5.  A mechanism-based proof of concept study on the effects of duloxetine in patients with painful knee osteoarthritis.

Authors:  Nadia Ammitzbøll; Lars Arendt-Nielsen; Davide Bertoli; Christina Brock; Anne Estrup Olesen; Andreas Kappel; Asbjørn Mohr Drewes; Kristian Kjær Petersen
Journal:  Trials       Date:  2021-12-27       Impact factor: 2.279

6.  Association between temporal summation and conditioned pain modulation in chronic low back pain: baseline results from 2 clinical trials.

Authors:  Jiang-Ti Kong; Dokyong Sophia You; Christine Sze Wan Law; Beth D Darnall; James J Gross; Rachel Manber; Sean Mackey
Journal:  Pain Rep       Date:  2021-12-08

7.  Signs Indicative of Central Sensitization Are Present but Not Associated with the Central Sensitization Inventory in Patients with Focal Nerve Injury.

Authors:  Luis Matesanz-García; Ferran Cuenca-Martínez; Ana Isabel Simón; David Cecilia; Carlos Goicoechea-García; Josué Fernández-Carnero; Annina B Schmid
Journal:  J Clin Med       Date:  2022-02-18       Impact factor: 4.964

8.  Gold micro-particles for knee osteoarthritis.

Authors:  Sten Rasmussen; Kristian Kjaer Petersen; Martin Kaae Kristiansen; Jakob Skallerup; Christopher Aboo; Mikkel Eggert Thomsen; Emilie Skjoldemose; Nia Kristine Jørgensen; Allan Stensballe; Lars Arendt-Nielsen
Journal:  Eur J Pain       Date:  2022-02-01       Impact factor: 3.651

9.  The effect of duloxetine on mechanistic pain profiles, cognitive factors and clinical pain in patients with painful knee osteoarthritis-A randomized, double-blind, placebo-controlled, crossover study.

Authors:  Kristian Kjaer-Staal Petersen; Asbjørn Mohr Drewes; Anne Estrup Olesen; Nadia Ammitzbøll; Davide Bertoli; Christina Brock; Lars Arendt-Nielsen
Journal:  Eur J Pain       Date:  2022-06-13       Impact factor: 3.651

Review 10.  Peripheral pain mechanisms in osteoarthritis.

Authors:  Tonia L Vincent
Journal:  Pain       Date:  2020-09       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.